CIBRA Capital’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

CIBRA Capital’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-94,495	Closed	-$907K	–	38
2024 Q4	$907K	Buy	+94,495	New	+$493K	0.62%	22

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CIBRA Capital's PSTX Position: Q1 2025 in Review

CIBRA Capital sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 94,495 shares — an estimated $907K sold.

CIBRA Capital first reported a position in PSTX in Q4 2024 and held it in 1 quarter. The position peaked at $907K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

CIBRA Capital reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
CIBRA Capital sold 94,495 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $907K.
CIBRA Capital first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
CIBRA Capital's Poseida Therapeutics, Inc. Common Stock position peaked at $907K in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on CIBRA Capital's 13F filing for Q1 2025, filed 28 Apr 2025.